
Cureverse
Operator of a pharmaceutical research and development company intended for the treatment of brain diseases and multiple sclerosis. The company develops small-molecule drugs for Alzheimer's and Parkins...
Valuation
$0
Share Price
N/A
Total Raised
$77.3M
Last Round
N/A